REGENERON PHARMACEUTICALS, INC. - 8-K Filing
Regeneron granted CEO and CSO one-time equity awards tied to long-term pipeline and revenue goals; formed new subsidiary with executive stakes (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $REGN